NCT01754857 2023-06-27
Bendamustine and Rituximab Induction Therapy and Maintenance Rituximab and Lenalidomide in Previously Untreated CLL/SLL
University of Wisconsin, Madison
Phase 2 Completed
University of Wisconsin, Madison
Institut de Cancérologie de la Loire
H. Lee Moffitt Cancer Center and Research Institute